Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma
- 26 January 2001
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 91 (1) , 67-74
- https://doi.org/10.1016/s0166-0934(00)00245-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNAJournal of Virological Methods, 1999
- Comparison of the QUANTIPLEX HIV-1 RNA 2.0 Assay with the AMPLICOR HIV-1 MONITOR 1.0 Assay for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma of Patients Receiving Stavudine-Didanosine Combination TherapyJournal of Clinical Microbiology, 1998
- Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in PlasmaJournal of Clinical Microbiology, 1998
- Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyAIDS, 1998
- A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/mlNucleic Acids Research, 1997
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivityJournal of Clinical Microbiology, 1997
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996